Frontlight ResearchEarly access
Myelodysplastic syndromes trials in United States
224 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePreemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
- Where
- Boston
- Age
- 18 years and over
- People
- 15
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06138587 - Phase 1Taking peopleStudy of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- Where
- Atlanta, Aurora, Baltimore, Birmingham, Boston, Charleston, Chicago, Cleveland, Columbus, Dallas, Detroit, Duarte, Durham, Houston, Jacksonville, Los Angeles, Miami, Nashville, New York, Phoenix, Portland, San Francisco, St Louis, Tampa
- Age
- 18 years and over
- People
- 291 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT02074839 - Phase 1/2Taking peopleCladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 80
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04047641 - Phase 1Taking peopleA Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- Where
- Rochester, Scottsdale
- Age
- 18 years and over
- People
- 99
- Run by
- Mayo Clinic
See details and how to joinNCT03017820 - No phaseTaking peopleInvestigation of the Genetics of Hematologic Diseases
- Where
- Memphis
- People
- 1,716
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT02720679 - Phase 2Taking peopleA Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts
- Where
- Houston
- Age
- 18 years and over
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05365035 - Phase 2Taking peopleAlpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
- Where
- Gainesville
- Age
- 6 months to 39 years
- People
- 20
- Run by
- University of Florida
See details and how to joinNCT05800210 - Early phase 1Taking peopleHyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Where
- Rochester
- Age
- 18 years to 75 years
- People
- 24
- Run by
- Omar Aljitawi
See details and how to joinNCT03964506 - Phase 2Taking peopleResearch On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)
- Where
- Aurora
- Age
- 18 years and over
- People
- 10
- Run by
- University of Colorado, Denver
See details and how to joinNCT07579429 - Phase 2Taking peopleA Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
- Where
- Canton, Duarte, Goodyear, Houston, Irvine, New Haven
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06847867 · EU 2024-519928-24-00 - Phase 2Taking peopleDonor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Where
- Seattle
- Age
- 6 months and over
- People
- 60
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT04195633 - Phase 1Taking peopleStudy to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
- Where
- Houston
- Age
- 18 years and over
- People
- 18 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953897 · EU 2024-516291-16-00 - Phase 1Taking peopleStudy to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
- Where
- Houston
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953910 · EU 2024-516292-33-00 - Phase 2Taking peopleA Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 76
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04239157 - Phase 1Taking peopleHA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Where
- Seattle
- Age
- Up to 80 years
- People
- 24
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT03326921 - Early phase 1Taking people5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies
- Where
- Cleveland
- Age
- 18 years and over
- People
- 20
- Run by
- Benjamin Tomlinson
See details and how to joinNCT04187703 - Phase 1/2Taking peopleChemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
- Where
- Seattle
- Age
- 18 years and over
- People
- 36
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT06928662 - Phase 2Taking peopleCord Blood Transplantation in Children and Young Adults With Blood Cancer
- Where
- New York
- Age
- Up to 26 years
- People
- 71
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07566377 - No phaseTaking peopleMCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
- Where
- Milwaukee
- Age
- 0 years to 25 years
- People
- 40
- Run by
- Medical College of Wisconsin
See details and how to joinNCT05794880 - Phase 1Taking peoplePhase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
- Where
- Charlottesville
- Age
- 18 years and over
- People
- 23
- Run by
- University of Virginia
See details and how to joinNCT07270978 - No phaseTaking peopleStudy of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- Where
- Boston, Brighton, Kalamazoo, Londonderry, Methuen, Milford, Weymouth
- Age
- 18 years and over
- People
- 10,000
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT02269592 - Phase 1Taking peopleStudy of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- Where
- Boston, Chapel Hill, Chicago, Cincinnati, Columbus, Houston, Salt Lake City
- Age
- 13 years and over
- People
- 100
- Run by
- Newave Pharmaceutical Inc
See details and how to joinNCT04771572 - No phaseTaking peopleComparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Where
- Birmingham, Duarte, Fresno, Fruitdale, Fullerton, Honolulu, Las Vegas, Los Angeles, Mather, Mobile, Monterey, Palo Alto, Salt Lake City, San Francisco
- Age
- 18 years and over
- People
- 2,996
- Run by
- Stanford University
See details and how to joinNCT05297734 - Phase 1/2Taking peopleLeflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes
- Where
- Morgantown
- Age
- 18 years and over
- People
- 26
- Run by
- West Virginia University
See details and how to joinNCT06923488 - Phase 2Taking peopleMT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
- Where
- Minneapolis
- Age
- 2 years to 75 years
- People
- 132
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT07493538